BIOGEN INC. is 3.6x more valuable than QIAGEN N.V. by market capitalization ($28.68 B vs $8.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QGEN | BIIB |
|---|---|---|
| Market cap | $8.03 B | $28.68 B |
| US-listed rank | #1070 | #476 |
| Revenue (latest FY) | $2.09B | $9.89B |
| Net income (latest FY) | $424.88M | $1.29B |
| Net margin | 20.3% | 13.1% |
| P/E (trailing FY) | 18.9 | 22.2 |
| SEC filings | 471 | 2,690 |
BIOGEN INC. is 3.6x more valuable than QIAGEN N.V. by market capitalization ($28.68 B vs $8.03 B).
In their latest fiscal years, QIAGEN N.V. reported $2.09B in revenue while BIOGEN INC. reported $9.89B.
Full pages: QIAGEN N.V. and BIOGEN INC., or browse the full rankings.